v.231201
Showing details for project SYSMHC00035
| SampleID |
NumReplicates |
Organism |
TissueType |
CellType |
MHCAllele |
| SampleID |
NumReplicates |
Organism |
TissueType |
CellType |
MHCAllele |
| SYSMHC00035_160226_MDM_C1R-C0102 |
5 |
Human |
|
|
HLA-C01:02 |
| SYSMHC00035_160226_MDM_C1R-C1203 |
5 |
Human |
|
|
HLA-C12:03 |
| SYSMHC00035_160226_MDM_C1R-E0101 |
5 |
Human |
|
|
HLA-E01:01 |
| SYSMHC00035_160324_MDM_C1R-C0303 |
5 |
Human |
|
|
HLA-C03:03 |
| SYSMHC00035_160324_MDM_C1R-C1402 |
5 |
Human |
|
|
HLA-C14:02 |
| SYSMHC00035_160324_MDM_C1R-G0101 |
5 |
Human |
|
|
HLA-G01:01 |
| SYSMHC00035_160416_MDM_C1R-C0401 |
5 |
Human |
|
|
HLA-C04:01 |
| SYSMHC00035_160416_MDM_C1R-C0802 |
5 |
Human |
|
|
HLA-C08:02 |
| SYSMHC00035_160416_MDM_C1R-C1502 |
5 |
Human |
|
|
HLA-C15:02 |
| SYSMHC00035_160416_MDM_C1R-C1601 |
5 |
Human |
|
|
HLA-C16:01 |
| SYSMHC00035_160416_MDM_C1R-C1701 |
5 |
Human |
|
|
HLA-C17:01 |
| SYSMHC00035_160608_MDM_C1R-C0202 |
5 |
Human |
|
|
HLA-C02:02 |
| SYSMHC00035_160608_MDM_C1R-C0304 |
5 |
Human |
|
|
HLA-C03:04 |
| SYSMHC00035_160608_MDM_C1R-C0501 |
5 |
Human |
|
|
HLA-C05:01 |
| SYSMHC00035_160608_MDM_C1R-C0602 |
5 |
Human |
|
|
HLA-C06:02 |
| SYSMHC00035_160608_MDM_C1R-C0701 |
5 |
Human |
|
|
HLA-C07:01 |
| SYSMHC00035_160608_MDM_C1R-C0702 |
5 |
Human |
|
|
HLA-C07:02 |
Detailed view of sample SYSMHC00035_160416_MDM_C1R-C1601
| ID |
SampleID |
RawFileName |
Organism |
Process |
Tissue Type |
Cell Type |
Culture Conditions |
Disease State |
Comments |
MHCClass |
MHCAllele |
PubMed ID |
Peptide |
Isolation Method |
Antibody |
Mass Spectrometer |
LC System |
iRT Peptides |
Acquisition Mode |
Fragmentation Method |
Gradient |
Gradient Length |
Flow Rate |
Replicate Number |
| ID |
SampleID |
RawFileName |
Organism |
Process |
Tissue_Type |
Cell_Type |
Culture_Conditions |
Disease_State |
Comments |
MHCClass |
MHCAllele |
PubMed_ID |
Peptide |
Isolation_Method |
Antibody |
Mass_Spectrometer |
LC_System |
iRT_Peptides |
Acquisition_Mode |
Fragmentation_Method |
Gradient |
Gradient_Length |
Flow_Rate |
Replicate_Number |
| SYSMHC00035 |
SYSMHC00035_160416_MDM_C1R-C1601 |
160416_MDM_C1R-C1601_W_20_5_400-650mz_CIDqisOT_25cm90min7s_msms23.raw |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
|
class I |
HLA-C16:01 |
28904123 |
native |
Immunoaffinity |
W6/32 |
Orbitrap Fusion Lumos |
nanoUHPLC, UltiMate 3000 RSLCnano |
no |
DDA |
HCD |
|
|
|
1 |
| SYSMHC00035 |
SYSMHC00035_160416_MDM_C1R-C1601 |
160416_MDM_C1R-C1601_W_20_4_400-650mz_CIDqisOT_25cm90min7s_msms22.raw |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
|
class I |
HLA-C16:01 |
28904123 |
native |
Immunoaffinity |
W6/32 |
Orbitrap Fusion Lumos |
nanoUHPLC, UltiMate 3000 RSLCnano |
no |
DDA |
HCD |
|
|
|
2 |
| SYSMHC00035 |
SYSMHC00035_160416_MDM_C1R-C1601 |
160416_MDM_C1R-C1601_W_20_1_400-650mz_CIDqisOT_25cm90min7s_msms19.raw |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
|
class I |
HLA-C16:01 |
28904123 |
native |
Immunoaffinity |
W6/32 |
Orbitrap Fusion Lumos |
nanoUHPLC, UltiMate 3000 RSLCnano |
no |
DDA |
HCD |
|
|
|
3 |
| SYSMHC00035 |
SYSMHC00035_160416_MDM_C1R-C1601 |
160416_MDM_C1R-C1601_W_20_2_400-650mz_CIDqisOT_25cm90min7s_msms20.raw |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
|
class I |
HLA-C16:01 |
28904123 |
native |
Immunoaffinity |
W6/32 |
Orbitrap Fusion Lumos |
nanoUHPLC, UltiMate 3000 RSLCnano |
no |
DDA |
HCD |
|
|
|
4 |
| SYSMHC00035 |
SYSMHC00035_160416_MDM_C1R-C1601 |
160416_MDM_C1R-C1601_W_20_3_400-650mz_CIDqisOT_25cm90min7s_msms21.raw |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
|
class I |
HLA-C16:01 |
28904123 |
native |
Immunoaffinity |
W6/32 |
Orbitrap Fusion Lumos |
nanoUHPLC, UltiMate 3000 RSLCnano |
no |
DDA |
HCD |
|
|
|
5 |